Sonnet BioTherapeutics Holdings, Inc. - Common Stock (SONN)
5.0889
+1.1689 (29.82%)
NASDAQ · Last Trade: Jul 7th, 3:56 PM EDT
Detailed Quote
Previous Close
3.920
Open
5.740
Bid
5.080
Ask
5.090
Day's Range
4.540 - 6.000
52 Week Range
1.080 - 10.02
Volume
29,393,903
Market Cap
16.11M
PE Ratio (TTM)
-0.3758
EPS (TTM)
-13.5
Dividend & Yield
N/A (N/A)
1 Month Average Volume
7,206,173
Chart
About Sonnet BioTherapeutics Holdings, Inc. - Common Stock (SONN)
Sonnet Biotherapeutics Holdings Inc is a biotechnology company focused on the development of innovative therapies for various diseases, particularly in the field of immuno-oncology. The company leverages its proprietary technology platform to create biologic drugs that aim to harness the body's immune system to target and eliminate cancer cells. Through a combination of advanced engineering and scientific expertise, Sonnet is working to deliver novel treatments that could provide meaningful benefits to patients in need, addressing unmet medical needs in oncology and other therapeutic areas. Read More
In today’s volatile small-cap landscape, several companies trading under $3 are making bold strategic moves across the consumer health, biotech, industrial, and mobility tech sectors—each positioning for significant growth.
Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN) fell 5.54% on Thursday to close at $3.92, before rebounding 14.29% in after-hours trading to $4.48, amid concerns of a potential NASDAQ delisting.
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
